0001116502-05-000177.txt : 20120705
0001116502-05-000177.hdr.sgml : 20120704
20050203122130
ACCESSION NUMBER: 0001116502-05-000177
CONFORMED SUBMISSION TYPE: SC 13G/A
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050203
DATE AS OF CHANGE: 20050203
GROUP MEMBERS: AUGUSTINE LAWLOR
GROUP MEMBERS: CHRISTOPHER MIRABELLI, PH.D.
GROUP MEMBERS: HAROLD R. WERNER
GROUP MEMBERS: HEALTHCARE PARTNERS V, L.P.
GROUP MEMBERS: HEALTHCARE VENTURES V, L.P.
GROUP MEMBERS: JAMES H. CAVANAUGH, PH.D.
GROUP MEMBERS: JOHN W. LITTLECHILD
GROUP MEMBERS: WILLIAM CROUSE
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: DYAX CORP
CENTRAL INDEX KEY: 0000907562
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 043053198
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-60267
FILM NUMBER: 05572210
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQ BLDG 600 5TH FL
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
MAIL ADDRESS:
STREET 1: ONE KENDALL SQ BLDG 600
STREET 2: 5TH FL
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTAGE INC
DATE OF NAME CHANGE: 19951117
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: HEALTHCARE VENTURES V L P
CENTRAL INDEX KEY: 0001022423
IRS NUMBER: 223487780
FILING VALUES:
FORM TYPE: SC 13G/A
BUSINESS ADDRESS:
STREET 1: 44 NASSAU ST
CITY: PRINCETON
STATE: NJ
ZIP: 08542
BUSINESS PHONE: 9089064600
MAIL ADDRESS:
STREET 1: 44 NASSAU ST
CITY: PRINCETON
STATE: NJ
ZIP: 08542
SC 13G/A
1
dyaxsc13ga.txt
SCHEDULE 13G AMENDMENT NO. 3
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------------
OMB APPROVAL
---------------------------------
OMB Number: 3235-0145
Expires: December 31, 2005
Estimated average burden
hours per response.............11
SCHEDULE 13G
Under the Securities and Exchange Act of 1934
(Amendment No. __3_)*
DYAX CORP.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
26746E103
--------------------------------------------------------------------------------
(CUSIP Number)
December 31, 2004
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[_] Rule 13d-1(b)
[_] Rule 13d-1(c)
[X] Rule 13d-1(d)
----------
* The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 26746E103 13G
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Ventures V, L.P.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 26746E103 13G
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
HealthCare Partners V, L.P.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0%
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
PN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 26746E103 13G
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
James H. Cavanaugh, Ph.D.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 26746E103 13G
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Harold R. Werner
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 26746E103 13G
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
William Crouse
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 26746E103 13G
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
John W. Littlechild
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 23,000
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 23,000
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
23,000
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.07%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 26746E103 13G
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Christopher Mirabelli, Ph.D.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 26746E103 13G
________________________________________________________________________________
1. NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (ENTITIES ONLY)
Augustine Lawlor
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
United States
________________________________________________________________________________
NUMBER OF 5. SOLE VOTING POWER
SHARES 0
_________________________________________________________________
BENEFICIALLY 6. SHARED VOTING POWER
OWNED BY 0
_________________________________________________________________
EACH 7. SOLE DISPOSITIVE POWER
REPORTING 0
_________________________________________________________________
PERSON 8. SHARED DISPOSITIVE POWER
WITH 0
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
[_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON*
IN
________________________________________________________________________________
*SEE INSTRUCTIONS BEFORE FILLING OUT!
CUSIP No. 26746E103 13G
Item 1(a). Name of Issuer:
Dyax Corp.
____________________________________________________________________
Item 1(b). Address of Issuer's Principal Executive Offices:
300 Technology Square
Cambridge, Massachusetts 02139
____________________________________________________________________
Item 2(a). Name of Person Filing:
HealthCare Ventures V, L.P. ("HCV V"), HealthCare Partners V,
L.P. ("HCP V"), Drs. Cavanaugh and Mirabelli and Messrs.
Werner, Littlechild, Crouse and Lawlor. See attached Exhibit
A, which is a copy of their agreement in writing to file this
statement on behalf of each of them.(1)
____________________________________________________________________
Item 2(b). Address of Principal Business Office, or if None, Residence:
The business address for HCV V, HCP V, Dr. Cavanaugh and
Messrs. Werner and Crouse is 44 Nassau Street, Princeton, New
Jersey 08542. The business address for Dr. Mirabelli and
Messrs. Littlechild and Lawlor is 55 Cambridge Parkway,
Cambridge, Massachusetts 02142.
____________________________________________________________________
Item 2(c). Citizenship:
HCV V, and HCP V are limited partnerships organized under the
laws of the State of Delaware. Drs. Cavanaugh and Mirabelli
and Messrs. Werner, Littlechild, Crouse and Lawlor are each
United States citizens.
____________________________________________________________________
Item 2(d). Title of Class of Securities:
Common Stock par value $.01 (the "Shares")
____________________________________________________________________
----------
(1) Drs. Cavanaugh and Mirabelli and Messrs. Werner, Littlechild, Crouse and
Lawlor are general partners of HCP V, the general partner of HCV V, the
record holder of the Issuer's Common Stock reported hereto.
CUSIP No. 26746E103 13G
Item 2(e). CUSIP Number:
26746E103
____________________________________________________________________
Item 3. If This Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b)
or (c), Check Whether the Person Filing is a: Not Applicable
(a) [_] Broker or dealer registered under Section 15 of the Exchange Act.
(b) [_] Bank as defined in Section 3(a)(6) of the Exchange Act.
(c) [_] Insurance company as defined in Section 3(a)(19) of the Exchange
Act.
(d) [_] Investment company registered under Section 8 of the Investment
Company Act.
(e) [_] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
(f) [_] An employee benefit plan or endowment fund in accordance with
Rule 13d-1(b)(1)(ii)(F);
(g) [_] A parent holding company or control person in accordance with
Rule 13d-1(b)(1)(ii)(G);
(h) [_] A savings association as defined in Section 3(b) of the Federal
Deposit Insurance Act;
(i) [_] A church plan that is excluded from the definition of an
investment company under Section 3(c)(14) of the Investment
Company Act;
(j) [_] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
CUSIP No. 26746E103 13G
Item 4. Ownership.
Provide the following information regarding the aggregate number and
percentage of the class of securities of the issuer identified in Item 1.
(a) Amount beneficially owned:
As of December 31, 2004: HCV V, HCP V Drs. Cavanaugh and Mirabelli and
Messrs Werner, Crouse and Lawlor did not own any Shares of the
Issuer's Common Stock; Mr. Littlechild beneficially owned 23,000
Shares of the Issuer's Common Stock.
______________________________________________________________________
(b) Percent of class:
As of December 31, 2004: HCV V, HCP V Drs. Cavanaugh and Mirabelli and
Messrs Werner, Crouse and Lawlor did not own any Shares of the
Issuer's Common Stock (0%); the 23,000 Shares beneficially owned by
Mr. Littlechild constituted 0.07% of the Shares outstanding.
______________________________________________________________________
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote:
Mr. Littlechild has the sole power to vote or direct the vote as to
the 23,000 Shares of the Issuer's Common Stock beneficially owned by
him.
(ii) Shared power to vote or to direct the vote:
None.
(iii) Sole power to dispose or to direct the disposition of:
Mr. Littlechild has the sole power to dispose of or to direct the
disposition of the 23,000 Shares of the Issuer's Common Stock
beneficially owned by him.
(iv) Shared power to dispose or to direct the disposition of:
None.
CUSIP No. 26746E103 13G
Item 5. Ownership of Five Percent or Less of a Class.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities check the following [X].
_______________________________________________________________________
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Not Applicable.
_______________________________________________________________________
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported on by the Parent Holding Company or Control
Person.
Not Applicable.
_______________________________________________________________________
Item 8. Identification and Classification of Members of the Group.
Not Applicable.
_______________________________________________________________________
Item 9. Notice of Dissolution of Group.
Not Applicable.
______________________________________________________________________
Item 10. Certifications. By signing below, I certify that, to the best of
my knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing
the control of the Issuer of the securities and were not acquired and are not
held in connection with or as a participant in any transaction having that
purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 2, 2005 HealthCare Ventures V, L.P.
Princeton, New Jersey By: its General Partner, HealthCare Partners V, L.P.
By: /s/ Jeffrey Steinberg
-----------------------------------------
Jeffrey Steinberg, Administrative Partner
February 2, 2005 HealthCare Partners V, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------------------
Jeffrey Steinberg, Administrative Partner
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------------------
James H. Cavanaugh, Ph.D
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------------------
Harold Werner
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------------------
William Crouse
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts--------------------------------------------------------
John W. Littlechild
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts--------------------------------------------------------
Christopher Mirabelli, Ph.D.
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts--------------------------------------------------------
Augustine Lawlor
EXHIBIT A
AGREEMENT
JOINT FILING OF SCHEDULE 13G
The undersigned hereby agree to jointly prepare and file with regulatory
authorities a Schedule 13G and any future amendments thereto reporting each of
the undersigned's ownership of securities of Dyax Corp. Corporation and hereby
affirm that such Schedule 13G is being filed on behalf of each of the
undersigned.
February 2, 2005 HealthCare Ventures V, L.P.
Princeton, New Jersey By: its General Partner, HealthCare Partners V, L.P.
By: /s/ Jeffrey Steinberg
-----------------------------------------
Jeffrey Steinberg, Administrative Partner
February 2, 2005 HealthCare Partners V, L.P.
Princeton, New Jersey
By: /s/ Jeffrey Steinberg
-----------------------------------------
Jeffrey Steinberg, Administrative Partner
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------------------
James H. Cavanaugh, Ph.D
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------------------
Harold Werner
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Princeton, New Jersey --------------------------------------------------------
William Crouse
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts--------------------------------------------------------
John W. Littlechild
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts--------------------------------------------------------
Christopher Mirabelli, Ph.D.
February 2, 2005 /s/ Jeffrey Steinberg, Attorney-in-Fact
Cambridge, Massachusetts--------------------------------------------------------
Augustine Lawlor
Note. Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7 for other parties
for whom copies are to be sent.
Attention. Intentional misstatements or omissions of fact constitute federal
criminal violations (see 18 U.S.C. 1001).